Medilot

Medilot

Created using Figma
MediLOT ICO是一个独特的基于分层双块链的EHR生态系统,它将控制和数据层之上的机器学习和数据分析功能结合在一起,并在我可以实现的系统上构建具有复杂应用的机器学习API。

通过具有记录所有交易的分配分类帐(Hyperledger ++),可以由授权临床使用的医护人员随时搜索整个长期患者数据。这些健康记录可以在不同机构之间获得患者批准。
To be announced
令牌详细信息
断续器
LOT
接受的货币
ETH
公司详情
注册国家
Singapore
额外细节
分类
平台, 健康

关于 Medilot

MediLOT是一个基于双区块链的EHR生态系统,具有独特的分层架构,在其控制和数据层之上集成了机器学习和数据分析功能,允许在系统之上构建具有复杂应用程序的机器学习API。 / p>

通过使用记录所有交易的分布式分类帐(Hyperledger ++),可以由授权的医疗从业人员随时检索整个纵向患者数据以供临床使用。然后,经患者许可,可以在不同的机构中访问这些健康记录。例如,访问以前从未接受过治疗的医院的患者将不需要重复调​​查,因为获得访问权限的医生或临床医生可以通过MediLOT访问他的整个健康记录。此外,差异性同意选择,例如涉及器官捐赠,预先医疗指示和研究的选择,也可以记录在区块链上并普遍获得。具体而言,可以以精细的方式捕获涉及使用数据进行研究的同意选择,使研究人员能够立即辨别患者是否同意将其数据用于研究,包括使用其生物材料,以及是否重新如果需要,可以进行识别。

%name%Roadmap

  • Q1 2019

  • Lite Mainnet up in community clinic setting.
  • Q2 2019

  • Complete ForkBase Integration.
  • Q3 2019

  • Testnet up in hospital setting.
  • Q1 2020

  • Limited Mainnet with core functionality in one geographical cluster.
  • 阅读更多
  • Q2 2020

  • GEMINI Trial.
  • Q4 2020

  • Mainnet online in Singapore.
  • Q2 2021

  • Asia Mainnet launch.

Medilot 球队

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Ooi Beng Chin
Founder
未验证
Ngiam Kee Yuan
Founder
未验证
Marcus Tan
Founder
未验证
Zhang Meihui
Founder
未验证
Zhang Jiangwei
Founder
未验证
Xiao Xiaokui
未验证
Zhang Dongxiang
未验证
Cai Qingchao
未验证
Dinh Tien Tuan Anh
未验证
Andreea Costea
未验证
Dumitrel Loghin
未验证
Lin Qian
未验证
Wang Sheng
未验证
Luo Zhaojing
未验证
Ruan Pingcheng
未验证
Tan Cheng
未验证
Xie Zhongle
未验证
Zheng Kaiping
未验证
Zhou Xuxuan
未验证

顾问

验证 0%

注意。未经证实的成员实际上可能不是团队成员

James Yip
未验证

5 ICO

$70 511 254

Shaun Djie
未验证
Gene Yan
未验证
Phan Vee Leung
未验证
Wang Ping
未验证

Medilot 最新消息

N/A
5.0 9
WEB2 轮廓 视力 活动 潜在 产品 球队

%name%Reviews

ICO Pantera
A+
阅读更多
Midgard Research

We believe that MediLOT is one of the exciting upcoming IEO and here are the reasons why:
First of all, the project is formulated and executed by a Singapore-based team with solid experience in medicine, tech and business development. The core members are from the blockchain and healthcare spheres:
- Co-founder Professor Beng Chin Ooi is 1 of the 2 Distinguished Professors and has spent over 30 years at the National University of Singapore's Department of Computer Science
- Co-founder Professor Meihui Zhang is a Professor at the Beijing Institute of Technology and a winner of prestigious China's Young Scholar Thousand Talents Program in 2018
- Co-founder Dr Marcus Tan is an Opthalmologist (Eye Specialist) and a Clinical Lecturer at the National University of Singapore
- CEO Koon Swee Lim has 25 years of senior management experience in healthcare industry, biomedical technology commercialisation and investments
The research done by MediLOT's team of professors has been cited in many reputable publications. 
Backed by equity investor SG Innovate, the Singapore Government Venture Capital Fund, MediLot has a monopoly in Singapore, having already partnered with National University Hospital (the largest medical research institution in Singapore). More contracts with other Singapore hospitals will be announced. The team has also secured a foothold in the fast-growing China healthcare market.  
Secondly, we like the idea of the project because it has a real use-case with seamless adoption of blockchain in our daily life. In summary, MediLOT is a dual blockchain-based Electronic Health Records platform that allows individual patients to grant healthcare providers, research institutions and pharmaceuticals access to their encrypted medical data by indicating the storage location. This is a highly secure solution which adheres to GDPR and other stringent data privacy regulations. Patients will be incentivized and empowered to permit the usage of their data to facilitate research, such as the research to create new drugs and treatments for cancers.
Thirdly, the token metrics is reasonable while the tokenomics is deflationary. IEO hardcap is $1,500,000 (for 8.5% of total token supply) while the initial circulating supply is $2,168,366. LOT Tokens retained by the MediLOT Platform will be burnt.  
Last but not least, Ricky Ng, the founder of Bitsdaq, is one of the advisors, so we will keep an eye on it. Probably it will be an IEO on Bitsdaq Exchange

阅读更多
Crypto Calibur
82

Medilot has flown under the radar for many of us not focused on developments in Asia but the project has a number of strong points. These include the fact that Medilot is operating in a lucrative sector and has a very much needed use case and is attempting to disrupt an industry that has been using outdated methods for quite some time. On top of this, the project has already developed an MVP and various aspects of the code are available to be verified. Medilot also has a strong core team with partnerships/collaborations with the National University of Singapore, the National University Health System, Singapore, and Chinese hospitals such as the Shandong Province Hospital, the Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, and the Shenzhen Kingcome Hospital.
They have also been backed by SGInnovate, Signum Capital, and two other renowned investors who wish to remain private. which shows they are developing something significant, however, due to the scope of the project Medilot could prove to be a slow burner. There is a long wait until the mainnet with a launch set for Singapore in Q4 2020, and the Asia launch is in Q3 2021. This will leave the LOT token open to pure speculation for quite a while and could even allow the market to grow cold on the project. In addition, in the long term LOT tokens rely on adoption to maintain value and there’s no guarantee this will happen anytime soon. Furthermore, the team do state that in the preliminary stage, organisations who do not wish to stake LOT can deposit fiat which will be treated as a security deposit. This won’t help the token price when the project is getting off the ground, however, the team aim to retain 30% of all LOT Tokens via the platform’s fee structure regarding data sharing. Also LOT tokens held by the Platform will be held to insure against Black Swan events, and may also be burnt by the management as well as locked up by institutions and organisations that choose to stake tokens. The low token sale ratio also increases the importance of the team’s token management; however, with the team getting ready to conduct an IEO, there should be enough positive price action to attract anyone looking for short term returns. Anyone looking to follow the project in the long term should keep an eye on developments and adoption community growth over the next year as the project nears its first mainnet launch.

阅读更多
dbcrypto
B
阅读更多
G.Crypto
阅读更多
查看全部(%count%)
  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。